Verified peer comparison
BeLive Holdings vs CytoMed Therapeutics Financial Comparison
Direct answer
BeLive Holdings and CytoMed Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in SGD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free BeLive Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- BeLive Holdings Revenue
- 757,159 SGD
- CytoMed Therapeutics Revenue
- 319,201 SGD
- BeLive Holdings Operating income
- -6,706,466 SGD
- CytoMed Therapeutics Operating income
- -4,519,770 SGD